Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.0744 | 0.5 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.3329 | 0.3329 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.0408 | 0.4821 | 0.4821 |
Echinococcus granulosus | mitogen activated protein kinase kinase kinase | 0.0408 | 0.4821 | 0.4821 |
Onchocerca volvulus | 0.0058 | 0.0561 | 1 | |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0744 | 0.0744 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0073 | 0.0744 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.3329 | 0.3329 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0415 | 0.4902 | 0.4902 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0561 | 0.0561 |
Loa Loa (eye worm) | hypothetical protein | 0.0408 | 0.4821 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.0744 | 0.0744 |
Brugia malayi | Protein kinase domain containing protein | 0.0408 | 0.4821 | 1 |
Loa Loa (eye worm) | TKL/MLK/LZK protein kinase | 0.0408 | 0.4821 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0744 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0744 | 0.5 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.0561 | 0.1163 |
Loa Loa (eye worm) | hypothetical protein | 0.0408 | 0.4821 | 1 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.0561 | 0.0561 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0744 | 0.5 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.0744 | 0.0744 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 1 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0744 | 0.0744 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.3329 | 0.6905 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0286 | 0.3329 | 0.6905 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.0744 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 6.3096 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (binding) | = 10 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ] | ChEMBL. | No reference |
Potency (functional) | 30.1313 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 95.2834 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.